Cargando…
Pretreatment serum CRP and response to interleukin 2.
Autores principales: | Blay, J. Y., Négrier, S., Philip, T., Favrot, M., Mercatello, A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968782/ https://www.ncbi.nlm.nih.gov/pubmed/8286207 |
Ejemplares similares
-
Intravenous interleukin-2 in patients over 65 with metastatic renal carcinoma.
por: Négrier, S., et al.
Publicado: (1992) -
Reply to the letter from Blay et al: Pretreatment serum CRP and response to interleukin 2
por: Heys, Steven D., et al.
Publicado: (1994) -
Correlation between clinical response to interleukin 2 and HLA phenotypes in patients with metastatic renal cell carcinoma.
por: Bain, C., et al.
Publicado: (1997) -
Renal cell carcinoma induces interleukin 10 and prostaglandin E(2) production by monocytes
por: Ménétrier-Caux, C, et al.
Publicado: (1999) -
Pretreatment serum markers and lymphocyte response to interleukin-2 therapy
por: Fumagalli, L, et al.
Publicado: (1999)